RecruitingNCT05452291

Multiomics Biomarkers for Urolithiasis

Exploring Multiomics Biomarkers for Urolithiasis


Sponsor

Chinese University of Hong Kong

Enrollment

1,200 participants

Start Date

May 27, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective case series study. To compare urine sample of recurrent stone-formers and non-stone former by multiomics approach to identify potential markers for stone recurrence.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking for biological markers (from blood, urine, or tissue) that can help explain why some people get kidney stones repeatedly. Understanding these biomarkers may lead to better prevention and treatment of recurrent kidney stones. You may be eligible if: - You are 18 or older - You have a history of 2 or more kidney stone episodes (both sides count as separate episodes) - OR you have never had a kidney stone and are willing to serve as a healthy comparison participant You may NOT be eligible if: - You refuse or are unable to give consent - You have an active urinary tract infection - Your stones are radiolucent (not visible on standard X-ray) or are infection-related stones Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Prince of Wales Hospital

Shatin, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05452291


Related Trials